ARTICLE | Company News
TheraTech deal
April 24, 1995 7:00 AM UTC
The initial product, an estradiol patch, is in Phase III trials. The Salt Lake City company plans to file an NDA late this year.
A second product in Phase I trials co-administers estradiol and progestin to treat post-menopausal symptoms and to prevent osteoporosis, while reducing the risk of developing endometrial hyperplasia. ...